Literature DB >> 3008902

Prognostic factors in breast cancer and the development of a prognostic index.

R M Bryan, R J Mercer, R C Bennett, G C Rennie.   

Abstract

A number of different factors are known to be correlated with survival of patients with breast cancer. Among these are lymph node status, tumour size, oestrogen receptor (ER), progesterone receptor (PR) and androgen receptor (AR) status. The purpose of this study was to investigate the relative significance of these factors and use this information to construct a prognostic index capable of predicting survival. These factors together with age and menopausal status were studied and correlated with prognosis in 796 women with primary breast cancer. The data were analysed in a stepwise manner by the Cox proportional hazards regression technique. Statistically, greater than 3 nodes involved gave the worst prognosis (P less than 0.001). This was followed by ER if less than 10 fmol/mg cytosol protein (P less than 0.001), PR if less than 10 fmol (P less than 0.01), greater than 0 lymph nodes involved (P less than 0.01) and the number of years over age 65 (P less than 0.01). When these factors were accounted for, tumour size, menopausal status and AR did not significantly improve prediction of survival. The significant factors were incorporated into a prognostic index: I = N + E + P + A, where N = 0 if no nodes involved, 13 (if 1-3 nodes involved and 31 if greater than 3 nodes involved, E = 15 if ER less than 10 fmol, P = 12.5 if PR less than 10 fmol and A = number of years over 65. Using this index five year survival curves were constructed corresponding to groups of patients with widely differing prognoses. Predicted five year survival ranged from 96 to 12 per cent.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3008902     DOI: 10.1002/bjs.1800730408

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

1.  The Nottingham Prognostic Index in primary breast cancer.

Authors:  M H Galea; R W Blamey; C E Elston; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Prognostic factors in breast cancer: the value of the Nottingham Prognostic Index for patients treated in a single institution.

Authors:  Homa Okugawa; Daigo Yamamoto; Yoshiko Uemura; Noriko Sakaida; Masanori Yamada; Kanji Tanaka; Yasuo Kamiyama
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

3.  Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.

Authors:  H O Wintzer; M Benzing; S von Kleist
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

4.  Rearrangement of chromosome 1p in breast cancer correlates with poor prognostic features.

Authors:  P J Hainsworth; K L Raphael; R G Stillwell; R C Bennett; O M Garson
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

5.  HER2 expression in fine needle aspirates of lymph nodes detected by preoperative axillary ultrasound in breast cancer patients.

Authors:  Ji Soo Choi; Hyun Ok Kim; Eun-Kyung Kim; Young Joo Suh; Jung Hyun Yoon; Hee Jung Moon; Min Jung Kim
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

6.  Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation.

Authors:  T Hasebe; H Tsuda; Y Tsubono; S Imoto; K Mukai
Journal:  Jpn J Cancer Res       Date:  1997-06

7.  The prognostic value of immunoperoxidase staining with monoclonal antibodies NCRC-11 and 3E1.2 in breast cancer.

Authors:  I M Muir; R G Reed; S A Stacker; A I Alexander; I F McKenzie; R C Bennett
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.